Sakar Healthcare

Sakar Healthcare

351.50
-1.45
(-0.41%)
hide
Key Fundamentals
Add Ratio
Market Cap
785.30 Cr
EPS
7.97
PE Ratio
39.58
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
394.95
52 Week Low
210.10
PB Ratio
2.66
Debt to Equity
0.30
Forecast For
Actual

Company News

View All News
Caret
positive
Sakar Healthcare reported a net profit of Rs 46.7 million for Q1, marking a significant increase from Rs 24 million in the same period last year. The company's EBITDA grew to Rs 127 million from Rs 107 million year-over-year. However, the EBITDA margin declined to 24.1% from 26% in the previous year's corresponding quarter.
positive
Sakar Healthcare has expanded its export potential by receiving approvals for anti-cancer injections in Europe. The company has obtained its third and fourth marketing authorizations for oncology injections in the European market. Sakar Healthcare is preparing for commercial supply of these products to Europe.
positive
Sakar Healthcare expects to receive Marketing Authorization System (MAS) approval gradually over the next few months. This approval will accelerate the export of various oncology products to the European Union. The company has already received its second marketing authorization for an oncology injection in the EU.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,679.10
#1 3,98,049.70
38.75
#1 54,729.00
9.71
#1 10,980
-19.84
61.71
6,621.50
1,75,222.50
76.19
9,712.00
18.67
2,191
26.74
72.60
1,577.60
1,26,768.90
23.67
28,409.50
7.12
5,291
9.88
60.63
3,584.30
1,19,599.80
60.49
11,539.40
6.99
1,911
19.91
53.74
1,255.90
1,03,508.80
#1 18.25
33,741.20
16.73
5,725
1.26
48.97
2,476.60
1,01,344.60
53.48
12,744.20
#1 20.90
2,007
-18.14
47.04
987.65
99,073.80
21.09
23,511.00
18.55
4,615
2.60
45.37
1,940.00
89,121.90
23.79
22,909.50
13.74
3,306
#1 51.64
46.82
5,581.50
66,047.70
28.61
13,458.30
3.70
2,216
21.39
63.11
1,101.00
64,254.10
19.04
32,345.60
9.43
3,484
-10.24
50.87
Growth Rate
Revenue Growth
-
Net Income Growth
-
Cash Flow Change
39.07 %
ROE
-
ROCE
-
EBITDA Margin (Avg.)
-

Quarterly Financial Results

Quarterly Financials
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
20
26
27
22
31
32
30
38
29
31
35
43
41
35
38
44
42
43
44
50
53
Expenses
16
19
23
15
24
25
23
28
21
22
25
33
30
25
28
32
31
31
32
35
40
EBITDA
5
7
4
8
7
8
7
10
8
9
11
10
11
10
9
12
11
12
12
16
13
Operating Profit %
23 %
27 %
14 %
33 %
21 %
22 %
22 %
25 %
28 %
28 %
26 %
19 %
23 %
27 %
24 %
25 %
26 %
27 %
27 %
31 %
24 %
Depreciation
1
1
1
5
2
2
3
3
4
4
4
4
5
4
4
5
5
5
5
6
6
Interest
1
1
1
0
1
1
1
1
1
1
2
2
2
2
2
2
1
2
1
4
2
Profit Before Tax
3
6
2
2
4
5
3
6
4
4
5
4
4
4
3
5
5
5
6
6
5
Tax
1
1
1
1
0
3
3
-3
1
3
1
0
1
1
1
2
2
0
1
1
1
Net Profit
3
5
2
2
4
3
0
9
3
2
4
4
3
4
2
3
2
5
5
6
5
EPS in ₹
1.72
3.04
1.20
1.17
2.15
1.44
0.07
5.07
1.65
1.01
2.16
2.04
1.46
1.68
0.98
1.46
1.10
2.17
2.08
2.66
2.11

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
115
178
268
336
389
415
Fixed Assets
66
69
205
267
314
309
Current Assets
22
34
50
56
72
89
Capital Work in Progress
13
49
1
7
0
17
Investments
0
0
7
3
0
0
Other Assets
36
60
55
60
74
90
Total Liabilities
115
178
268
336
389
415
Current Liabilities
14
33
47
55
59
63
Non Current Liabilities
20
46
94
109
67
67
Total Equity
81
99
128
173
262
286
Reserve & Surplus
66
83
110
154
236
261
Share Capital
15
16
17
19
22
22

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-0
-0
-0
0
0
-0
Investing Activities
-22
-47
-90
-74
-52
-31
Operating Activities
19
15
36
33
25
34
Financing Activities
4
32
55
41
27
-4

Share Holding

% Holding
Feb 2021
Mar 2021
Apr 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Jul 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
74.02 %
74.02 %
67.54 %
67.54 %
67.54 %
67.54 %
67.54 %
67.54 %
62.10 %
62.10 %
62.10 %
60.72 %
60.72 %
54.15 %
53.15 %
53.15 %
53.15 %
53.15 %
53.58 %
53.58 %
52.86 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
13.76 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.62 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
16.44 %
15.57 %
16.21 %
17.43 %
19.40 %
19.35 %
18.95 %
19.38 %
17.82 %
17.67 %
17.62 %
18.41 %
18.13 %
16.37 %
16.61 %
16.78 %
16.80 %
16.88 %
15.75 %
15.93 %
15.86 %
Others
9.54 %
10.41 %
16.25 %
15.03 %
13.06 %
13.12 %
13.51 %
13.09 %
20.09 %
20.24 %
20.29 %
20.87 %
21.15 %
29.48 %
5.86 %
30.07 %
30.05 %
29.97 %
30.67 %
30.48 %
31.28 %
No of Share Holders
2,049
307
2,444
4,604
6,481
6,542
6,702
6,091
6,092
5,678
6,210
6,322
6,056
6,057
7,001
7,386
7,313
7,867
8,598
8,608
8,115

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
20 Dec 2023 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
20 Dec 2023 393.70 372.25
21 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
21 Sept 2024 332.50 325.20
22 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
22 Oct 2024 317.60 317.50
08 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
08 Feb 2025 272.55 274.80
15 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 May 2025 269.05 310.75

Technical Indicators

RSI(14)
Neutral
48.26
ATR(14)
Less Volatile
14.58
STOCH(9,6)
Neutral
29.08
STOCH RSI(14)
Oversold
5.44
MACD(12,26)
Bearish
-1.60
ADX(14)
Strong Trend
28.51
UO(9)
Bearish
35.73
ROC(12)
Downtrend And Accelerating
-1.91
WillR(14)
Oversold
-87.87